Archive - BowTiedBiotech

Your Weekly Biotech News Fix | Ep. 951

The week of 3.2.2026

58 mins ago

Ribosomes as Drug Targets. The Quiet Rewrite of Psychiatry and Beyond. | Ep. 950

Therapeutics will be defined by translational pulse, not receptor binding.

18 hrs ago

ADC Saturation: Is Oncology Becoming a Me-Too Battlefield? | Ep. 949

A crowded oncology gold rush - or the beginning of ADC saturation?

Mar 4

21:59

BIOTECH MARKET RESEARCH $RLAY | Ep. 948

Relay Therapeutics

Mar 2

The Illusion of Movement | Ep. 947

Why Biotech Stocks Aren’t Going Anywhere Without Real Liquidity

Mar 1

February 2026

GLP-1 Pill Wars and Single Trial Approvals | Ep. 946

Competition intensifies, regulators recalibrate, and biotech’s risk-reward equation gets rewritten in real time.

Feb 28

20:25

Your Weekly Biotech News Fix | Ep. 945

The week of 2.23.2026

Feb 27

Higher Cost of Capital. Tighter Private Biotech. | Ep. 944

How structural compression changed round size, timelines, and exits

Feb 26

Why AI Drugs Fail in Humans | Ep. 943

AI speeds discovery, but translation is still the bottleneck.

Feb 25

20:23

BIOTECH MARKET RESEARCH $IDYA | Ep. 942

Ideaya Biosciences

Feb 23

The Extinction of Diversified Pharma | Ep. 941

Focus wins. Ruthless portfolio prioritization is the new biotech moat.

Feb 23

The FDA Shreds The Rulebook | Ep. 940

FDA rewrites the rules as biotech bets billions.

Feb 21

21:15

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts